Ledger.Open graph →
SEC Form D · filed August 30, 2022

AiVita Biomedical, Inc

Offering
$85.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
IRVINE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Philippe Schaison · Irvine, CADirectorAlexander Suh · Irvine, CADirectorMatthew Katz · Irvine, CADirectorPaul Jenkinson · Irvine, CADirectorScott Burell · Irvine, CAExecHans Keirstead · Irvine, CAExec · DirectorUngbae Lee · Irvine, CADirectorEric Kanowsky · Santa Barbara, CADirectorDan Myers · San Diego, CADirectorKokila Doshi · San Diego, CADirectorBrian Coryat · Santa Barbara, CAExec · DirectorPraful Doshi · San Diego, CADirectorFrank Chen · San Diego, CADirectorHouman Hemmati · San Diego, CAExecChris Fibiger · Irvine, CADirectorChris R. Adams · SAN FRANCISCO, CADirectorPeter R. Christodoulo · SAN FRANCISCO, CAExec · DirectorThomas R. Ludwig · SAN FRANCISCO, CAExecRama Kakrlapudi · Louisville, KYDirectorVasu Kakarlapudi · Louisville, KYDirectorApta Properties LLC · Louisville, KYDirectorWilliam Moran · Waltham, MADirectorChris Fibiger · Irvine, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗